NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



HIV/AIDS



New HIV/AIDS study findings recently were published by researchers at University of Bristol



June 24th, 2008

According to a study from Bristol, the United Kingdom, "Estimates of the number of prevalent human immunodeficiency virus infections are used in U.K. and Wales to monitor development of the human immunodeficiency virus-acquired immune deficiency syndrome epidemic and for planning purposes. The population is split into risk groups, and estimates of risk group size and of risk group prevalence and diagnosis rates are combined to derive estimates of the number of undiagnosed infections and of the overall number of infected individuals."

"In traditional approaches, each risk group size, prevalence or diagnosis rate parameter must be informed by just one summary statistic....


Source: TB & Outbreaks Week (2008-06-24)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login